Search for Clinical Trial Results

Sponsored By

Parotitis - 24 Studies Found

Status Study
Not yet recruiting Study Name: Gender and Opioid Consumption
Condition: Postoperative; Parotitis
Date: 2016-12-27
Interventions: Drug: postoperative morphine Postoperatively, A loading dose of morphine will be given in incremental do
Not yet recruiting Study Name: Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants
Condition: Epidemic Parotitis,Mumps
Date: 2017-04-17
Interventions:
  • Biological: ≥3.0 lgCCID50/mlbut ＜3.5lgCCID50/ml Live Attenuated
Recruiting Study Name: SPI-directed Analgesia for Vitreoretinal Surgeries
Condition:
  • Vitreoretinal Surgeries
  • Postoperative Nausea and Vomiting

  • Date: 2016-11-22
    Interventions:
    • Drug: Metamizol in group A pat
Active, not recruiting Study Name: Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants
Condition: Mumps
Date: 2016-02-23
Interventions:
  • Biological: investigational live attenuated mumps vaccine

Completed Study Name: A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children
Condition: The Study Focused on the Safety of Attenuated Mumps Vaccine (Human Diploid Cell) Against Mumps in Chinese Adults, Children and Infants.
Date: 2012-10-22
Interventions:
  • Biological: 3.50±0.25logCCID50/ml

Recruiting Study Name: Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine
Condition:
  • Encephalitis, Japanese
  • Measles
  • Mumps
  • Biological: CD-JEV Single 0.5

Completed Study Name: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age
Condition: Measles; Mumps; Rubella
Date: 2014-07-03
Interventions:
  • Biological: GSK Biologicals measles, mumps and rubella vaccine live (GSK 209
Completed Study Name: Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older
Condition:
  • Rubella
  • Mumps
  • Measles

Date: 2014-02-06
Interventions:
  • Biological: Priorix® 1 do
Completed Study Name: Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.
Condition:
  • Measles
  • Mumps
  • Rubella
  • Va
    Date: 2013-11-08
    Interventions:
    • Biological: MMR Bio-Manguinhos

Completed Study Name: Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)
Condition:
  • Mumps
  • Rubella
  • Measles

Date: 2013-06-07
Interventions: Biological: MMR (Mumps, Measles and Rubella) MMR (Mumps, Measles and Rubella)
Next >>>